98%
921
2 minutes
20
Background: Progressive supranuclear palsy (PSP) is characterized by the presence of hyperphosphorylated and misfolded tau aggregates in neurons and glia. Recent studies have illuminated the prion-like cell-to-cell propagation of tau via exosomes. Recognizing the potential significance of excretion through urine as a crucial pathway for eliminating pathological tau from the central nervous system, this study aimed to investigate whether exosomes derived from the urine of PSP-Richardson's syndrome (PSP-RS) patients can elicit tau pathology and PSP-like symptoms in mice.
Methods: Urinary exosomes obtained from PSP-RS patients and normal controls (NCs) were stereotactically injected into the bilateral globus pallidus of mouse brains. Behavioral analyses were conducted every 3 months post-injection. After 6 months, mice were sacrificed for pathological evaluation.
Results: Elevated levels of phosphorylated tau and neural cell markers were observed in urinary exosomes from PSP-RS patients compared to NCs. At the 6-month mark post-injection, tau inclusions were evident in the brains of mice receiving urinary exosomes from PSP-RS patients, with widespread distribution in both injection sites and distant brain regions (cortex, hippocampus, and substantia nigra). Tau pathology manifested in neurons and astrocytes. Moreover, mice injected with urinary exosomes from PSP-RS patients exhibited impaired motor coordination and balance, mirroring PSP motor symptoms.
Conclusion: Our findings indicate that urinary exosomes from PSP-RS patients can induce tau pathology and trigger PSP-like motor symptoms in mice. This leads to the hypothesis that exosomes may play a role in the pathogenesis of PSP.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.brainresbull.2024.111046 | DOI Listing |
Clin Transl Med
September 2025
Department of Cardiology, Guangzhou Red Cross Hospital of Ji-Nan University, Guangzhou, China.
Background: To investigate the role of self-peripheral blood mesenchymal stem cell (PBMSC)-derived exosomes (Exos) in enhancing renal sympathetic denervation (RD)-mediated heart regeneration following myocardial infarction (MI) in a porcine model.
Methods: Pigs (ejection fraction [EF] < 40% post-MI) were randomised to early sham RD or RD. At 2 weeks post-MI, autologous PBMSC-Exos were collected.
Clin Proteomics
August 2025
Clinical Laboratory Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Background: Small cell lung cancer (SCLC) is an aggressive malignancy with a poor prognosis. This study aimed to analyze the urinary exosomal proteome of SCLC patients to identify and validate potential non-invasive biomarkers for improving diagnosis, treatment response monitoring, and prognosis prediction.
Methods: We analyzed 90 urine samples from SCLC patients, divided into training (n = 38) and validation (n = 52) sets, including untreated, partial/complete remission, and relapsed groups.
J Proteome Res
September 2025
Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.
Background: Podocytes injury drives proteinuria in diabetic kidney disease (DKD). Exosomes derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have demonstrated therapeutic potential in kidney diseases. However, the effects of hUCMSCs on podocyte injury and the underlying mechanisms in DKD remain unexplored.
View Article and Find Full Text PDFStem Cell Res Ther
August 2025
Department of Infectious Diseases, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Complicated urinary tract infection (cUTI), characterized by recurrent episodes due to multidrug-resistant bacterial infections and biofilm formation, severely compromises patients' quality of life. Although uropathogenic Escherichia coli remains the primary pathogen, its ability to form biofilms and induce persistent inflammatory responses exacerbates urothelial damage, thereby aggravating the disease. Current antibiotic treatments face resistance issues and inability to promote tissue repair, emphasizing the need for innovative treatments.
View Article and Find Full Text PDFInt J Nanomedicine
July 2025
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, LinKou Branch, Taoyuan, Taiwan.
Introduction: MicroRNAs (miRNAs) are small, non-coding RNA molecules critical for cellular function, growth, and development. Recent advances in remote diagnostic technologies have highlighted the potential of urinary miRNAs as non-invasive biomarkers for disease monitoring. This study introduces a simple, rapid, and cost-effective reagent for exosomal miRNA extraction, designed for urine-based exosome screening.
View Article and Find Full Text PDF